About Nick Olsen
Nick Olsen is a director at Character Biosciences.
Form D filings also name Nick Olsen as a board member at Averna Therapeutics.
Experience
This experience comes from Nick Olsen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Nick Olsen in the role, so the role may have started earlier or lasted longer.
LB
Leash Bio Current
Member Board of Directors
2026 – Present
AL
Altis Labs Current
Board Observer
2026 – Present
EL
Elio Current
Investor
2026 – Present
TB
Think Bioscience Current
Member Board of Directors
2025 – Present
ST
Syrna Therapeutics Current
Member Board of Directors
2025 – Present
Averna Therapeutics Inc. Current
Board Member
Member Board of Directors (2024 – Present)
2024 – Present · Watertown, MA
Develops gene insertion medicines for people with genetic diseases, cancer and autoimmune conditions.
WE
Weave Current
Investor
2023 – Present
IE
Innovation Endeavors Current
Partner
2021 – Present
TI
Tempus Labs, Inc.
Strategy and Operations
2018 – 2021
BC
Bain & Company
Associate Consultant, Senior Associate Consultant
2015 – 2018
SI
Spark Therapeutics, Inc.
Global Commercial
2017
Key Colleagues at Startups
The people Nick Olsen works with at each company, as listed on that company's latest Form D.
Averna Therapeutics Inc. · Form D/A, Mar 20, 2026
Thomas Barnes
CEO & Board Member
Roy Amariglio
Board Member
SS
Stephen Squinto
Director
MS
Michal Silverberg
Director
Raju Prasad
Board Member
Tal Zaks
Executive Chairman of the Board
Henry Chen
Board Member
DM
Dylan Morris
Board Member
Character Biosciences, Inc. · Form D, Sep 17, 2025
RS
Reut Shema
Director
VG
Vivek Garipalli
Director
MA
Mayssa Attar
Director
JK
James Kasuboski
Director
CZ
Cheng Zhang
CEO, CFO, and Secretary, director
PD
Peter DiLaura
Director
JH
Jason Hafler
Director